Key result
DOACs and anti-Xa agents might rival parenteral DVT prophylaxis after knee arthroplasty despite local bleeding.
Why the study?
What is the practical approach to DVT prophylaxis in patients undergoing knee arthroplasty?
What is the practical approach to DVT prophylaxis in patients undergoing knee arthroplasty?
This review suggests that while pharmacological prophylaxis effectively reduces DVT risk after knee arthroplasty, the choice of agent must balance efficacy with the risk of postoperative bleeding.
May support DOAC alternatives for post-knee arthroplasty DVT prophylaxis with bleeding caution; leaves open randomized confirmation.
Venous thromboembolism (VTE) is still a frequent and sometimes severe complication after knee replacement surgery. Both and non-pharmacological measures have been widely used to decrease VTE risk. Non pharmacological include measures directed to decrease the effects of blood stasis, intermittent pneumatic compression (IPCD) and graduated compression stockings, and mechanical devices. Pharmacological prophylaxis of venous (VTE) is associated with a more significant decrease in the incidence of deep venous thrombosis (DVT) related complications after knee arthroplasty however anticoagulation may increase the risk of postoperative bleeding related complications, in particular the need for re-intervention. Aim of present review was to suggest practical approach DVT prophylaxis in patients undergoing knee arthroplasty. parenteral drugs (low dose unfractionated heparin, low molecular weight heparin and fondaparinux) are the more employed agents, limited compliance may be a concern. Recent studies suggest that direct oral anticoagulants, and anti Xa agent, might be a useful alternative although safety may limited by an higher rate of local bleeding.
No takes yet. Share an insight, caveat, or question.
Rostagno et al. (2016) conducted a review in Venous thromboembolism in knee replacement surgery. DVT prophylaxis (pharmacological and non-pharmacological) was evaluated. Direct oral anticoagulants, antithrombin, and anti-Xa agents might be useful alternatives to parenteral drugs for DVT prophylaxis after knee arthroplasty, though safety may be limited by local bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: